Fuse™. Full Spectrum Endoscopy™. Colonoscopy is widely accepted as the gold standard for screening, surveillance, and diagnosis of lower GI diseases. However, endoscopy technology has not changed significantly in decades and interval cancers still occur1. In a tandem study using standard, forward-viewing (SFV) endoscopes, Rex et al. found they missed 24% of the adenomas in the first colonoscopy. Since that landmark study, other technologies have shown the miss rate for SFV to be 31%2.
Product URL : http://www.endochoice.com/Fuse
Last Updated : 05/02/2014